CDKN2A and diabetic kidney disease: These findings support the hypothesis that SYG, composed of Astragalus, Rheum, and Epimedium, may exert their anti-senescence and renoprotective effects in DKD by modulating the Klotho-mediated p16/p21 signaling pathway, providing a mechanistic basis for their clinical use.